| High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22 M Gulhane, L Murray, R Lourie, H Tong, YH Sheng, R Wang, A Kang, ... Scientific reports 6 (1), 28990, 2016 | 317 | 2016 |
| MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy SK Lindén, YH Sheng, AL Every, KM Miles, EC Skoog, THJ Florin, ... PLoS pathogens 5 (10), e1000617, 2009 | 310 | 2009 |
| Mucins in inflammatory bowel diseases and colorectal cancer YH Sheng, SZ Hasnain, THJ Florin, MA McGuckin Journal of gastroenterology and hepatology 27 (1), 28-38, 2012 | 209 | 2012 |
| MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli YH Sheng, S Triyana, R Wang, I Das, K Gerloff, TH Florin, P Sutton, ... Mucosal immunology 6 (3), 557-568, 2013 | 139 | 2013 |
| The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis YH Sheng, R Lourie, SK Lindén, PL Jeffery, D Roche, TV Tran, CW Png, ... Gut 60 (12), 1661-1670, 2011 | 128 | 2011 |
| Epitope studies with anti-β2-glycoprotein I antibodies from autoantibody and immunized sources SW Reddel, YX Wang, YH Sheng, SA Krilis Journal of autoimmunity 15 (2), 91-96, 2000 | 118 | 2000 |
| Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease J Wilson, H Cullup, R Lourie, Y Sheng, A Palkova, KJ Radford, ... Journal of Experimental Medicine 206 (2), 387-398, 2009 | 85 | 2009 |
| MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target YH Sheng, Y He, SZ Hasnain, R Wang, H Tong, DT Clarke, R Lourie, ... Oncogene 36 (5), 700-713, 2017 | 83 | 2017 |
| Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis KA Ramsey, ACH Chen, G Radicioni, R Lourie, M Martin, A Broomfield, ... American journal of respiratory and critical care medicine 201 (6), 661-670, 2020 | 76 | 2020 |
| MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance Y Sheng, CP Ng, R Lourie, ET Shah, Y He, KY Wong, I Seim, I Oancea, ... International journal of cancer 140 (10), 2351-2363, 2017 | 42 | 2017 |
| Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation TA Seldon, R Pryor, A Palkova, ML Jones, ND Verma, M Findova, K Braet, ... Leukemia 30 (3), 692-700, 2016 | 32 | 2016 |
| CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin Y He, CM Davies, BS Harrington, L Hellmers, Y Sheng, A Broomfield, ... Oncogene 39 (1), 219-233, 2020 | 31 | 2020 |
| Techniques for assessment of interactions of mucins with microbes and parasites in vitro and in vivo YH Sheng, SZ Hasnain, CW Png, MA McGuckin, SK Lindén Mucins: Methods and Protocols, 297-312, 2012 | 8 | 2012 |
| Developing a Therapeutic Anti-Dendritic Cell Antibody to Prevent Graft Versus Host Disease. D Hart, T Seldon, M Jones, Y Sheng, A Palkova, H Cullup, T Munro, ... Blood, The Journal of the American Society of Hematology 114 (22), 3554-3554, 2009 | 1 | 2009 |
| Targeted interleukin-22 therapy improves glycemic control, steatohepatitis, and fibrosis in experimental models of metabolic dysfunction-associated steatohepatitis H Sajiir, S Keshvari, KY Wong, D Borg, A Mueller, M Moniruzzaman, ... Journal of Gastroenterology and Hepatology 38, 37-37, 2023 | | 2023 |
| Thioguanine prevents colitis-associated cancer via beta-catenin signaling in intestinal epithelial cells independently of immunosuppression and autophagy Y Sheng, R Giri, J Davies, V Schreiber, S Alabbas, R Movva, Y He, A Wu, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 35, 106-106, 2020 | | 2020 |
| Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell … DNJ Hart, X Ju, Z Elgundi, N Verma, P Silveira, P Fromm, R Alingcastre, ... Blood 126 (23), 3081, 2015 | | 2015 |
| The human monoclonal antibody 3C12C targeting activated dendritic cells is a potential new immunosuppressive agent P Silveira, ND Verma, DJ Munster, TA Seldon, Y Sheng, ML Jones, ... TRANSPLANTATION 99 (11), S142-S143, 2015 | | 2015 |
| The Human Monoclonal Antibody 3C12C, Targeting Activated Dendritic Cells Is a Potential New Immunosuppressive Agent ND Verma, D Munster, T Seldon, YH Sheng, M Jones, T Munro, S Mahler, ... Biology of Blood and Marrow Transplantation 21 (2), S330-S331, 2015 | | 2015 |
| CD83 Expression On Human Immune Cells as a Target for Immunosuppression DNJ Hart, Z Elgundi, J Xinsheng, ND Verma, PA Silveira, PD Fromm, ... Immunology and Cell Biology 93 (9), A8-A8, 2015 | | 2015 |
